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Background: Advancements in cartilage tissue engineering have the potential to ameliorate
facial and joint reconstructive surgery as we know it. The translation of in vitro models of
cartilage regeneration into clinical scenarios is the next phase of cartilage tissue engi-
neering research. To engineer larger, more robust, and clinical relevant constructs, a great
number of viable chondrocytic cells are needed. However, there is a paucity of literature
concerning the most favorable method of chondrocyte isolation. Isolation methods are
inconsistent, resulting in small yields and poor cell quality, and thus unreliable neo-
cartilage formation. This study aimed to optimize the chondrocyte isolation protocol to
give a maximum yield with optimal cell viability for the engineering of large cartilaginous
constructs such as the human nose and ear.
Methods: We employed several enzymes (pronase, dispase, hyaluronidase, and collage-
nase), enzyme concentrations, and digest lengths to digest freshly harvested ovine naso-
septal cartilage. We used automated trypan blue live/dead staining, immunofluorescent
labeling of CD44, collagenase II, collagenase I, and Aggrecan, and alamarBlue to assess cell
yield and viability.
Results: Incubation length in enzymatic solutions had the greatest effect on cell viability,
whereas concentrations of enzymes had a lesser effect. Isolated cells maintained their
expression of chondrocyte-specific cell surface markers.
Conclusions: The optimum incubation period was 10 h using collagenase at a 0.2% (w/v)
solution. An average of 1e1.5  106 cells could be harvested per gram of cartilage using this
method.
ª 2013 Elsevier Inc. Open access under CC BY license.1. Introduction social insecurity and severe depression [1]. Even with theThe absence of key craniofacial structures, namely the nose
and ear, as a result of oncologic resection, trauma, or
congenital malformation can cause a patient to experienceotechnology and Regene
don NW3 2QG, United Kin
. Seifalian).
 CC BY license.advent of wax and silicone facial prostheses, patients report
a feeling of incompleteness. For many years, surgeons have
sought to reconstruct the nose and ear using autologous
transplantation of cartilage from the contralateral ear or ribs,rative Medicine, Division of Surgery and Interventional Science,
gdom. Tel./fax: þ44 207 830 2901.
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include postoperative scarring, pain, the risk of infection, and
poor healing at the donor site. In addition, the cartilage har-
vested is often too little or too rigid to effect a perfect aesthetic
and functional reconstruction [3].
The success of cartilage tissue engineering for the treat-
ment of osteoarthritic and rheumatologic disease has
prompted investigation into its application in engineering
facial cartilage. Tissue engineering employs biological or
synthetic scaffolds and complex cell differentiation tech-
niques to regenerate damaged or lost tissuewithin the body. A
sizeable amount of research has been conducted in devel-
oping whole or “off-the-shelf” tissue-engineered nasal and
auricular cartilage constructs. However, to date, most
attempts have been small-scale, producing mechanically
immature tissue prone to resorption in vivo [2,4].
To engineer bigger and better constructs, large populations
of viable chondrocytic cells are needed. The current zeitgeist
is that autologous mesenchymal stem cells would be an ideal
renewable cell source [5]. The application of this technology is
limited by difficulties in stopping the differentiation of
mesenchymal stem cells before they turn into osteoblasts
(thereby making bone) [6e8]. There is also a tendency, if
successfully differentiated, for these cells to produce imma-
ture and fragile neocartilage unsuitable for making three-
dimensional constructs [9]. In light of these issues, many
research groups continue to use mature adult chondrocytes
isolated from harvested cartilage to advance the development
of whole tissueeengineered constructs [10e12].
Cartilage is not themost cellular of tissues; only 5%e10% of
its volume consists of cells. These cells, known as chon-
drocytes, sit in fluid-filled spaces known as lacunae, sur-
rounded by a dense extracellularmatrix (ECM) of collagenases,
proteoglycans, and glycosaminoglycans (Fig. 1). During the
breakdown of the dense ECM, chondrocytes are often exposed
to harsh enzymes for prolonged periods of time. This reduces
not only the final cell number, but also the viability andFig. 1 e Scanning electron micrograph of a cross-section of
ovine nasoseptal cartilage. (A) Cartilage ECM secreted by
chondrocytes. (B) Chondrocytes in fluid-filled spaces known
as lacunae. (Color version of figure is available online.)proliferative capacity of the cells. To compensate for this,
many research groups have tried to increase cell number by
passaging; however, the propensity of chondrocytes to dedif-
ferentiate into fibroblasts over repeated passages is a major
problem [13e15]. Ideally, for engineering large constructs that
are to be in culture for a long time and tomaintain consistency
in tissue quality, huge numbers of cells with high viability and
minimal passage number should be used [15].
Recent studies have shown vast discrepancies in chon-
drocyte isolation practice (Table 1). Concentrations and types
of collagenase vary widely, as do the inclusion or exclusion of
predigest stages and variations in the optimal length of digest.
Such incongruous methodologies are doubtless responsible
for inconsistent cell numbers, function, and viability. As such,
this study aimed to optimize chondrocyte isolation practice
according to stages of digest, length of digest, and concen-
tration of enzymes. We assessed the cell number and viability
of the cells after digest and characterized the cell yield,
because the number of true chondrocytes in each harvest has
not yet been investigated in detail. We also optimized the
seeding density of these cells, because few studies have
investigated this, although it is crucial for understanding key
cell behaviors over prolonged culture periods.2. Material and methods
2.1. Optimization of chondrocyte isolation
2.1.1. Cartilage harvest
We harvested normal noses from 40 male sheep with a mean
age of 15 mo shortly after slaughter, and transported them in
unsupplementedDulbecco’sModified Eagle’sMedium (DMEM)
(Gibco, UK) at 4C to our laboratory. We harvested nasoseptal
cartilage and carefully dissected away the perichondrium.We
washed the cartilage three times with sterile phosphate-
buffered saline (PBS) (Gibco, UK) and minced it into 1-mm3
pieces. We washed the minced cartilage again and weighed it
out into 1 g/sample.
2.1.2. Evaluation of predigest
The samples underwent a 1-h predigestion stage with an
enzyme, either 0.8 U/mg Dispase (Sigma Aldrich, UK), 0.1%
hyaluronidase (Sigma Aldrich), or 0.4% pronase (Roche,
UK), dissolved in N-2-hydroxyhydroxyethylpiperazine-N0(2-
ethanesulphonic acid) (HEPES)-buffered DMEM (Gibco, UK)
supplemented with 50 U/50 mg/mL penicillin-streptomycin
(Sigma Aldrich), 2.5 mg/mL amphotericin B, and 10% fetal
bovine serum (FBS) (Gibco, UK) (Table 1). We filter-sterilized all
enzymes by passage through a 0.22-mm filter. We also used
a negative control of supplemented HEPES-buffered DMEM.
We used 10 mL solution per gram of cartilage. We then incu-
bated the cartilage pieces for 1 h at 37C on a shaker at about
30e40 rpm. The cartilage fragments were then washed twice
with PBS and subjected to collagenase II (Sigma Aldrich) 0.15%
digests for 10 h. We dissolved the collagenase II in supple-
mented HEPES-buffered DMEM media and sterile-filtered it.
We used 10 mL of this medium per gram of cartilage and
incubated the cartilage at 37C on a shaker without CO2.
Table 1 e Variation in chondrocyte isolation protocol: Overview of some of the methods used to isolate chondrocytes for
cartilage tissue engineering.
Species Enzymes Length of digest Cell yield/g Reference
Human Collagenase II: 0.2% 16 h 4.45  2.28  106 [18]
Human Collagenase II: 0.08% Overnight [19]
Human Collagenase II: 0.15% 22 h [20]
Human Collagenase II
Trypsin/EDTA
Hyaluronidase
Tosyl-lysyl chloromethane
Overnight <22% of available cells [21]
Human Deoxyribonuclease 1: 0.015%
Hyaluronidase: 0.1%
Collagenase II: 0.2%
18e36 h [22]
Rabbit Predigest with: Hyaluronidase: 0.05%
Collagenase II: 0.2%
Trypsin: 0.2%
1e2 h [23]
Human Trypsin
Protease
Hyaluronidase (varied concentrations)
Low-temperature method, 12 h 1.68  105/g [17]
Sheep Collagenase II: 0.3% 5e8 h [24]
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Once we established the optimum predigest condition, we
optimized collagenase II digestion using different concentra-
tions of collagenase 11 (0.1%, 0.15%, and 0.2%) for different
lengths of time (6, 10, and 16 h) (Table 2). We made the digest
media as stated above.
2.1.4. Chondrocyte harvest and culture
For all digests, we passed the triturate suspension through
a 100-mm nylon cell strainer (BD Falcon, UK) to remove matrix
debris, and added it to 40 mL DMEM/F-12 (1.1) with GlutaMAX
(DMEM/F-12) (Gibco, UK) media, supplemented with 20% FBS,
1% penicillin-streptomycin and 1% amphotericin B. The 20%
FBS helped neutralized enzyme activity and provide nutrients
to the shocked cells.We centrifuged the filtrate at 2000 rpm for
10 min to pellet the cells. We discarded the supernatant,
washed pelleted cells in sterile PBS, and resuspended them in
supplemented DMEM/F-12 (20% FBS).We performed cell countTable 2 e Digest schedule: Comparisons made between differe
digestions times, and concentrations.
Predigest*
Enzyme Concentration Time (min)
1 Dispase 0.8 U/mg 60
2 Hyaluronidase 0.1% (w/v) 60
3 Pronase 0.4% (w/v) 60
4 Control e 60
* All predigest experiment underwent additional collagenase II (0.15%) foand viability assessment using the Countess Cell Counter
(Invitrogen).
We plated harvested cells into flasks in 20% FBS DMEM/
F-12 supplemented media undisturbed for 3 d, in a humidi-
fied incubator at 37C and 5% CO2. This was to allow the cells
a period of recovery before experimentation or cryopreser-
vation. We seeded cells at a density of 1  106 cells per T-75
flask.
2.2. Characterization of cells
2.2.1. Histology
We seeded cells at a density of 1  104/T-25 flask. Before
staining, we rinsed the cells in sterile PBS and fixed them in
2.5% (w/v) glutaraldehyde/PBS for 30 min, and rinsed them
again with PBS. We used standard histological methods to
perform Alcian Blue (Sigma Aldrich, UK) and Neutral fast red
(Sigma, UK) staining to localize the glycosaminoglycannt enzymatic digestion protocols, showing enzymes used,
Collagenase digest
Enzyme Concentration Time (min)
5 Collagenase II 0.10% (w/v) 360
(a) 600
(b) 960
(c)
6 Collagenase II 0.15% (w/v) 360
(a) 600
(b) 960
(c)
7 Collagenase II 0.20% (w/v) 360
(a) 600
(b) 360
(c)
r 10 h.
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collagenase distribution and orientation, and Safranin O
(Sigma Aldrich, UK) to highlight the proteoglycan content.
We performed visualization and photography using a Nikon
(UK) TMS light microscope and Optem (UK) InfinityY2-1L
imaging system.
2.2.2. Immunofluorescence
We characterized cells according to the expression of specific
surface proteins. For CD44 (Lifespan Biosciences, UK), colla-
genase II, collagenase I, and Aggrecan (Millipore, UK), we
characterized by immunofluorescence imaging using mouse
host antibodies. We also used a secondary antibody of fluo-
rescein isothiocyanateeconjugated anti mouse immunoglob-
ulin G antibody along with a negative control of anti-mouse
immunoglobulin G2befluorescein isothiocyanate conjugate.
CD44 was conjugated to red fluorescent quantum dot
(synthesized in our lab) and used for labeling. We used a Zeiss
(UK) confocal microscope and C1 imaging software (UK).2.3. Optimization of seeding density
2.3.1. alamarBlue (AB)
alamarBlue (Serotec, Kidlington, UK) is used for the quanti-
tative measure of cell proliferation, cytotoxicity, and viability.
Resazurin and resarfurin are used as colorimetric indicators of
oxidation. These indicators respond by changing color
according to changes in cell metabolism. The color change is
measured at absorbances of 570 and 630 nm. The advantages
of this assay are that it is soluble in media, stable in solution,
and minimally toxic to cells, and produces changes that are
easily assessed [16]. To optimize the seeding density, we
cultured P0 cells for up to 14 d at the following densities:
1 103, 5 103, 1 104, 5  104, 1 105, 5 105 and 1  106. We
addedAB to cell culturemedia (CCM) at a concentration of 10%
(v/v). At each assay time point, we removed the media from
the wells, washed cells with 1 mL PBS, and added 1 mL AB/
CCM to the wells. We used AB/CCM in wells with no cells as
a negative control. After 4 h, we removed a 200-mL sample of
the AB/media and measured the absorbance at 570 and
630 nm in a 96-well plate (Nunc, Thermo Fisher Scientific, UK)
using the Fluoroskan AscentFL spectrofluorometer (Thermo
Lifesciences, Basingstoke, UK).Fig. 2 e Results of predigest evaluation. (A) Cell yield after 1 h.
viability (%). ***P< 0.0001. (Color version of figure is available o2.3.2. Lactate dehydrogenase assay (LDH)
We measured LDH using a CytoTox 96s nonradioactive cyto-
toxicity assay kit (Promega, Southampton, UK). The amount of
LDH released is measured using a 30-min coupled enzymatic
reaction based on the conversion of a tetrazolium salt INT
(2-p-iodophenyl-3-p-nitrophenyl-5-phenyl tetrazolium chlo-
ride) into a red formazan product. The amount of coloration
produced is directly proportional the number of lysed cells.
We transferred 50-mL samples of CCM from each well to
a 96-well plate (Thermo Fisher Scientific, UK). We added 50 mL
of substrate mix to each well and covered the plate in foil.
After a 30-min incubation period, we stopped the reaction by
adding 50 mL stop solution (1 mol/L acetic acid). We then read
the absorbance at 492 nm using an Anthos Microplate absor-
bance reader 2020, version 2 (Biochrom Ltd., Cambridge, UK).2.4. Statistics
Data are presented as means  standard deviation. We per-
formed comparisons between groups using one-way and two-
way analyses of variance along with Tukey’s and Dunnett’s
multiple comparison post-tests. We performed statistical
analysis using GraphPad Prism version 5.0 software (UK).
P < 0.05 was considered statistically significant.3. Results
3.1. Evaluation of predigest
After a 1-h digest period, there was no significant difference in
the number of cells produced when we used hyaluronidase or
pronase enzyme compared with the negative control (no
enzyme). Treatment with dispase enzyme produced a signifi-
cantly higher cell yield than in the control (P < 0.0001) (n ¼ 9)
(Fig. 2). Subjected to a continued digest for 10 h in 0.15%
collagenase II, there was no significant difference in the cell
yield between the control, dispase, and hyaluronidase
enzyme. The number of cells produced in the pronase group
was significantly less than the negative control (P < 0.0001)
(n ¼ 9) (Fig. 2). There was significant reduction in the viability
of the cells from all experimental groups compared with the
control (P < 0.0001) after the completed digest. Cells subjected(B) Cell yield after 1 h plus 10 collagenase II digest. (C) Cell
nline.)
Fig. 3 e Collagenase digest optimization. (A) Cell yield. (B) Cell viability. *P< 0.05. ***P< 0.0001. (Color version of figure is
available online.)
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groups (P < 0.0001) (n ¼ 9) (Fig. 2).
3.2. Optimization of collagenase digest
Therewas a significant increase in cell yield between 0.1% and
0.15% collagenase II. The increase seen between 0.15% and
0.2% at all three times was not significant. There was a signif-
icant increase in cell yield over time (P < 0.0001). We also
deemed the interaction between variables of concentration
and time to be statistically significant (P< 0.001) (n¼ 5) (Fig. 3).
We did not consider the effect of concentration on cell viability
to be significant, whereas time was a significant factor. The
decrease in viability could be attributed to time at all three
collagenase II concentrations (P < 0.0001) (n ¼ 5) (Fig. 3).
3.3. Cell characterization
We performed immunofluorescence on harvested chon-
drocytes to investigate their expression of chondrocyte
markers, CD44, collagenase II, collagenase I, and Aggrecan.
Chondrocytes strongly expressed CD44 and collagenase II, as
expected (Fig. 4A and B). There was also expression of
Aggrecan and collagenase I, but this was comparatively
reduced (Fig. 4C and D).Fig. 4 e ImmunohistochemistryofP2chondrocytesseededontissue
(B) FITC-labeled collagenase II. (C) FITC-labeled collagenase I. (D) FITOver the 4-, 7-, and 14-d culture period, the cells’ appear-
ance took on a more rounded morphology (Fig. 5). The cells
were confluent in T-25 flasks after a 14-d culture period, and
there was an increase in the amount of staining of all three
ECM proteins over that period.
3.4. Optimization of seeding density
Theoptimumseedingdensity formaintaininggoodcellviability
for chondrocytes ina24-well plateovera10-d incubationperiod
was 1 105 (P< 0.001) (Fig. 6). The cells in thiswell continuously
increased over the 10-d incubation period, evidencing potential
for continued growth over an extended culture period. Seeding
at 5  105 had the highest peak viability at Day 7, but suffered
a sharp decline in viability upuntil Day 10 (P< 0.001). Therewas
no significant difference in the results of the lactate dehydro-
genase assay.4. Discussion
The isolation of chondrocytes from cartilage for tissue engi-
neering research and therapeutics is a contentious issue. Each
laboratory has a unique method for isolating chondrocytes,
involving a number of different enzymes, incubation lengths,cultureplastic in24-wellplates. (A)Quantumdot-labeledCd44.
C-labeledAggrecan. (Color version of figure is available online.)
Fig. 5 e Histology staining of ECM proteins, collagenase, proteoglycan, and glycosaminoglycan in chondrocyte cultures at 4,
7, and 14 d. (Color version of figure is available online.)
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Fig. 6 e alamarBlue and lactate dehydrogenase results for
seeding density study.
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steadily towardwidespread use in vivo; a number of constructs
are implanted into humans, and chondrocytes are used in the
therapeutic treatment of osteoarthritis. In light of this, an
optimized, validated method for chondrocyte isolation needs
to be established and shared with other group. This would
serve as a step toward quality assurance. In addition, much of
the published literature focuses only on harvesting cartilage
from small amounts of cartilage, and therefore protocols
rarely work well when scaled up.
In this study, we optimized a protocol for isolating chon-
drocytes from nasoseptal cartilage that can be scaled up or
down to produce consistent results. We first investigated theFig. 7 e Images of optimal digest protocol and effect of time
and collagenase concentration on cell yield and viability.
(Color version of figure is available online.)
j o u r n a l o f s u r g i c a l r e s e a r c h 1 8 1 ( 2 0 1 3 ) 4 1e4 8 47necessity of a predigest phase in chondrocyte isolation. When
considering clinical application, simple and shortmethods are
of paramount importance. Our data suggest that the inclusion
of a predigest step serves no benefit for increasing the number
of viable cells yielded during harvest, and thus is not neces-
sary (Fig. 2).
We evaluated the incubation time and collagenase enzyme
concentration in light of previous published research. We
found a 10-h digest with an enzyme concentration of 0.2% to
be the most effective method for isolating the chondrocytes
(Fig. 7). Although increasing the length of incubation time to
16 h dramatically increased the cell yield, the viability was
severely reduced. The health of cells in tissue engineering is
equally important to the actual number of cells. Interestingly,
enzyme concentration did not have as significant an effect on
cell viability as the length of incubation time. This is likely the
result of a phenomenon observed in our laboratories: If
chondrocytes remain freely in suspension for longer than
24 h, they begin to die at fast rate.
We found the optimum seeding density to be 1  105 cells
(P < 0.001), allowing for a continued growth curve most likely
up until 14 d of incubation, enough time for most assays to be
conducted. Anything longer than this within a 14-d culture
periodwould lead to exaggerated cell death. For longer periods
of culture, the seeding density should be reduced.
The authors have used this protocol in the isolation of
human chondrocytes from articular and facial cartilage
sources. The results for cell yield and viability are comparable
(unpublished data). There is conservation in the types of ECM
proteins that are found within the cartilage of the sheep
animal model and humans. The nasoseptal cartilage of sheep
and humans are both of a hyaline cartilage subtype with
a dense collagenase II matrix.
We recommend a 10-h incubation period with 0.2% colla-
genase II enzyme for optimal chondrocyte yield and viability
for cartilage tissue, in which one can expect between 1 and
1.5  106 cells per gram of cartilage. The optimum seeding
density on tissue culture plastic 24-well plates is 1  105 for
a 10-d incubation. This should be optimized for the different
substrates on which the cells are to be grown, because the
seeding density is likely to differ.
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